IBDEI08D ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10993,0)
 ;;=364.41^^73^699^50
 ;;^UTILITY(U,$J,358.3,10993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10993,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,10993,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,10993,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,10994,0)
 ;;=364.05^^73^699^51
 ;;^UTILITY(U,$J,358.3,10994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10994,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,10994,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,10994,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,10995,0)
 ;;=365.02^^73^699^4
 ;;^UTILITY(U,$J,358.3,10995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10995,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,10995,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,10995,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,10996,0)
 ;;=372.63^^73^699^117
 ;;^UTILITY(U,$J,358.3,10996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10996,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,10996,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,10996,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,10997,0)
 ;;=372.75^^73^699^27
 ;;^UTILITY(U,$J,358.3,10997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10997,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,10997,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,10997,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,10998,0)
 ;;=364.81^^73^699^43
 ;;^UTILITY(U,$J,358.3,10998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10998,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,10998,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,10998,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,10999,0)
 ;;=006.9^^73^699^2
 ;;^UTILITY(U,$J,358.3,10999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10999,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,10999,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,10999,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,11000,0)
 ;;=190.8^^73^699^60
 ;;^UTILITY(U,$J,358.3,11000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11000,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,11000,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,11000,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,11001,0)
 ;;=224.1^^73^699^93
 ;;^UTILITY(U,$J,358.3,11001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11001,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,11001,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,11001,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,11002,0)
 ;;=360.33^^73^699^52
 ;;^UTILITY(U,$J,358.3,11002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11002,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,11002,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,11002,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,11003,0)
 ;;=224.8^^73^699^86
 ;;^UTILITY(U,$J,358.3,11003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11003,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,11003,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,11003,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,11004,0)
 ;;=364.01^^73^699^103
 ;;^UTILITY(U,$J,358.3,11004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11004,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,11004,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,11004,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,11005,0)
 ;;=364.04^^73^699^53
 ;;^UTILITY(U,$J,358.3,11005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11005,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,11005,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,11005,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,11006,0)
 ;;=364.21^^73^699^46
 ;;^UTILITY(U,$J,358.3,11006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11006,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,11006,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,11006,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,11007,0)
 ;;=364.23^^73^699^81
 ;;^UTILITY(U,$J,358.3,11007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11007,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,11007,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,11007,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,11008,0)
 ;;=364.51^^73^699^8
 ;;^UTILITY(U,$J,358.3,11008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11008,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,11008,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,11008,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,11009,0)
 ;;=364.53^^73^699^100
 ;;^UTILITY(U,$J,358.3,11009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11009,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,11009,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,11009,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,11010,0)
 ;;=364.57^^73^699^33
 ;;^UTILITY(U,$J,358.3,11010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11010,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,11010,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,11010,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,11011,0)
 ;;=364.60^^73^699^26
 ;;^UTILITY(U,$J,358.3,11011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11011,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,11011,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,11011,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,11012,0)
 ;;=364.73^^73^699^97
 ;;^UTILITY(U,$J,358.3,11012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11012,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,11012,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,11012,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,11013,0)
 ;;=364.75^^73^699^107
 ;;^UTILITY(U,$J,358.3,11013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11013,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,11013,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,11013,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,11014,0)
 ;;=364.76^^73^699^58
 ;;^UTILITY(U,$J,358.3,11014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11014,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,11014,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,11014,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,11015,0)
 ;;=364.77^^73^699^3
 ;;^UTILITY(U,$J,358.3,11015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11015,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,11015,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,11015,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,11016,0)
 ;;=364.89^^73^699^62
 ;;^UTILITY(U,$J,358.3,11016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11016,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,11016,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,11016,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,11017,0)
 ;;=364.9^^73^699^61
 ;;^UTILITY(U,$J,358.3,11017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11017,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,11017,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,11017,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,11018,0)
 ;;=370.00^^73^699^25
 ;;^UTILITY(U,$J,358.3,11018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11018,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,11018,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,11018,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,11019,0)
 ;;=370.20^^73^699^66
 ;;^UTILITY(U,$J,358.3,11019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11019,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,11019,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,11019,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,11020,0)
 ;;=370.31^^73^699^99
 ;;^UTILITY(U,$J,358.3,11020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11020,1,3,0)
 ;;=3^Phlyctenule Keratoconj
 ;;^UTILITY(U,$J,358.3,11020,1,4,0)
 ;;=4^370.31
 ;;^UTILITY(U,$J,358.3,11020,2)
 ;;=^268928^017.30
 ;;^UTILITY(U,$J,358.3,11021,0)
 ;;=370.8^^73^699^65
 ;;^UTILITY(U,$J,358.3,11021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11021,1,3,0)
 ;;=3^Keratitis,Oth Forms
 ;;^UTILITY(U,$J,358.3,11021,1,4,0)
 ;;=4^370.8
 ;;^UTILITY(U,$J,358.3,11021,2)
 ;;=^87595
 ;;^UTILITY(U,$J,358.3,11022,0)
 ;;=371.24^^73^699^23
 ;;^UTILITY(U,$J,358.3,11022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11022,1,3,0)
 ;;=3^Corneal Edema,Sec Contact Lens
 ;;^UTILITY(U,$J,358.3,11022,1,4,0)
 ;;=4^371.24
 ;;^UTILITY(U,$J,358.3,11022,2)
 ;;=^268969
 ;;^UTILITY(U,$J,358.3,11023,0)
 ;;=371.46^^73^699^88
 ;;^UTILITY(U,$J,358.3,11023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11023,1,3,0)
 ;;=3^Nodular Degeneration
 ;;^UTILITY(U,$J,358.3,11023,1,4,0)
 ;;=4^371.46
 ;;^UTILITY(U,$J,358.3,11023,2)
 ;;=^268981
 ;;^UTILITY(U,$J,358.3,11024,0)
 ;;=371.48^^73^699^98
 ;;^UTILITY(U,$J,358.3,11024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11024,1,3,0)
 ;;=3^Peripheral Degeneration
 ;;^UTILITY(U,$J,358.3,11024,1,4,0)
 ;;=4^371.48
 ;;^UTILITY(U,$J,358.3,11024,2)
 ;;=^268982
 ;;^UTILITY(U,$J,358.3,11025,0)
 ;;=371.49^^73^699^34
 ;;^UTILITY(U,$J,358.3,11025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11025,1,3,0)
 ;;=3^Degeneration,Other
 ;;^UTILITY(U,$J,358.3,11025,1,4,0)
 ;;=4^371.49
 ;;^UTILITY(U,$J,358.3,11025,2)
 ;;=^268983
 ;;^UTILITY(U,$J,358.3,11026,0)
 ;;=371.52^^73^699^18
 ;;^UTILITY(U,$J,358.3,11026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11026,1,3,0)
 ;;=3^Cornea Dystrophy,Anterior Other
 ;;^UTILITY(U,$J,358.3,11026,1,4,0)
 ;;=4^371.52
 ;;^UTILITY(U,$J,358.3,11026,2)
 ;;=^268985
 ;;^UTILITY(U,$J,358.3,11027,0)
 ;;=371.53^^73^699^47
 ;;^UTILITY(U,$J,358.3,11027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11027,1,3,0)
 ;;=3^Granular Dystrophy
 ;;^UTILITY(U,$J,358.3,11027,1,4,0)
 ;;=4^371.53
 ;;^UTILITY(U,$J,358.3,11027,2)
 ;;=^52826
 ;;^UTILITY(U,$J,358.3,11028,0)
 ;;=371.54^^73^699^80
 ;;^UTILITY(U,$J,358.3,11028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11028,1,3,0)
 ;;=3^Lattice Dystrophy
 ;;^UTILITY(U,$J,358.3,11028,1,4,0)
 ;;=4^371.54
 ;;^UTILITY(U,$J,358.3,11028,2)
 ;;=^268986
 ;;^UTILITY(U,$J,358.3,11029,0)
 ;;=371.55^^73^699^82
 ;;^UTILITY(U,$J,358.3,11029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11029,1,3,0)
 ;;=3^Macular Dystrophy
 ;;^UTILITY(U,$J,358.3,11029,1,4,0)
 ;;=4^371.55
 ;;^UTILITY(U,$J,358.3,11029,2)
 ;;=^73074
 ;;^UTILITY(U,$J,358.3,11030,0)
 ;;=371.56^^73^699^116
